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SObjective:A bronchopleural fistula (BPF) is a serious complication after pulmonary resection and carries a high
mortality rate. It remains a therapeutic challenge. The lack of a consensus suggests that no optimal therapy is
available; however, endoscopic closure of a fistula may avoid extensive and potentially risky surgery.
Methods: Seventeen patients (15 men and 2 women) with a BPF after a pneumonectomy (n¼ 2) or a lobectomy
(n ¼ 15), seen between 1995 and 2010, were reviewed. Their median age was 50 years (range, 14-75 years).
Underlying diseases were malignant (n ¼ 4) and nonmalignant (n ¼ 13).
Results: The mean interval between surgery and fistula development was 20 days (range, 5-270 days). Clinical
symptoms leading to a diagnosis of BPF were a persistent air leak (n ¼ 2), a persistent air leak associated with
pleural empyema (n¼ 3), pleural empyema alone (n ¼ 11), and dyspnea (n ¼ 1). Mean fistula size was 3.3 mm
(range, 2-9 mm). Treatment consisted of oriented pleural drainage, adequate antibiotic therapy, and endoscopic
closure of the fistula with local application of silver nitrate through a flexible bronchoscope (3-15 sessions,
3 times per week). Fistula closure was successful in 16 patients, but failed in 1 patient, who died from acute
respiratory distress.
Conclusions: BPF is a severe complication in thoracic surgery. The combination of pleural drainage, adequate
antibiotic treatment, and mucosal application of silver nitrate, through a flexible bronchoscope, is an efficient
alternative and avoids extensive surgical intervention. (J Thorac Cardiovasc Surg 2013;146:575-9)A bronchopleural fistula (BPF) is a cavity that develops
between the bronchial tree and the pleural space. It is a se-
vere complication after pulmonary resection and carries
a high mortality rate, ranging from 25% to 67%.1,2 The
management of this serious postoperative complication
remains a challenge. Therapeutic options range from
extensive surgical procedures, including trans-sternal me-
diastinal closure of the BPF, a repeat thoracotomy, thora-
coplasty, or chest-wall fenestration, followed by filling
the cavity, to several other conservative bronchoscopic
techniques.3
Closure of a fistula using endoscopy constitutes a thera-
peutic alternative, and can avoid major surgery. Thus, al-
though a wide variety of bronchoscopic procedures have
been developed recently, no gold standard has yet been es-
tablished regarding the treatment of choice. Therefore, we
aimed, in this retrospective study, to evaluate the effective-
ness and safety of applying silver nitrate onto the bronchial
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We reviewed the records of all patients who had been treated for BPF in
our thoracic surgery department between 1995 and 2010. During that pe-
riod, we performed 1808 lobectomies (178 bilobectomies) and 427 pneu-
monectomies.We diagnosed 22 patients with BPF after a pneumonectomy
(4 patients, 0.93%) or a lobectomy (18 patients, 0.99%). Five of these pa-
tients were excluded because they had not undergone bronchoscopy.
We included the data from 17 patients (15 men and 2 women) who had
a postoperative bronchopleural fistula and had been treated with endo-
scopic injections of silver nitrate. Their median age was 50 years (range,
14-75 years). Resection had been conducted using the classic technique
(ie, dissection of the different vascular elements bound by nonabsorbable
thread, and these were then divided into sections). The bronchus of the
area concerned was dissected, and then cut with a blade and sutured with
Vicryl (Ethicon, Somerville, NJ) by applying cartilage onto cartilage or,
less frequently, cartilage onto mucosa. The bronchial stumps were covered
systematically by a pleural flap when the resection was on the right side.
Data were taken from hospital medical records and included age, under-
lying disease, side of the fistula, fistula size (mm) at initial bronchoscopy,
interval (days) between surgery and fistula discovery, and mode and num-
ber of endoscopic interventions.
A diagnosis of a BPF was suspected if there were clinical signs of a per-
sistent air leak, pleural empyema, dyspnea, or abundant sputum; radiolog-
ical signs included a hydropneumothorax, empyema, atelectasis, or
persistent pleural detachment. A diagnosis of a BPF was confirmed only
if discontinuity of the stump was visualized by bronchoscopy. Endoscopic
confirmation allowed us to avoid false positives.
The BPFs were divided according to the modified classification of Le
Brigand into ‘‘early fistula’’ if it occurred 1 to 7 days after surgery, ‘‘inter-
mediate’’ if it occurred 8 to 30 days after surgery, and ‘‘late’’ if it occurred
more than 30 days after surgery.4 We treated 1 early, 8 intermediate, and 8
late fistulas.
Fistula sizes and their localizations were evaluated by a pulmonologist
using fiberoptic endoscopy at the patient’s bedside. If a BPF was suspected,
immediate pleural drainage was performed, and specimens were taken for
bacterial analysis. In cases of pleural empyema, an all-day irrigationrdiovascular Surgery c Volume 146, Number 3 575
Abbreviation and Acronym
BPF ¼ bronchopleural fistula
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Ssystem (using 50 mL of povidone-iodine in 500 mL of saline, diluted to
0.9%, given at 0.5 to 1.5 L/24 h) was used for drainage and to control local
infection. Pleural drainage was performed until the empyema had resolved.
The chest tube could be removed when the drainage volume was less than
100 mL/24 h and there were no air leaks or signs of a persistent fistula, as
assessed by a radiological scan for incomplete lung expansion. All patients
received antibiotic therapy adjusted according to their antibiogram.
Endoscopic treatment consisted of one or more sessions of mucosal ap-
plication of silver nitrate to the edges of the fistula. Patients underwent flex-
ible bronchoscopy under local anesthesia of the laryngeal and tracheal
airways using 1% lidocaine. The first bronchoscopy assessed the lesions:
it gathered information on the bronchial stump and the number, location,
and size of the fistula(s). Thus, the fistula was recognized either directly,
within the bronchial orifice as it opened directly into the pleural cavity
(a large fistula), or indirectly, by seeing bubbling at the bronchial stump
during coughing or aspiration.
We used liquid 1% silver nitrate that had been prepared in an adequately
aerated room to avoid inspiration of its harmful vapors. A catheter (Com-
bicath 58223.19; Prodimed, Saint-Leu-La-Fore^t, France) was often used to
apply the silver nitrate for protection during distal bacteriological sampling
during resuscitation. A flexible bronchoscope was then positioned at 6 to 7
mm from the orifice of the fistula; the mucosal secretions were continu-
ously aspirated. Under direct vision, the silver nitrate applicator was passed
through the working channel of the bronchoscope, and 1 mL of the solution
was administered around the fistula’s mucosa. During this time, the patient
did not cough and avoided inhalation. The applicator was then retracted.
The procedure was repeated 3 times a week until closure of the BPF. The
criteria for a good result were the appearance of inflammation around the
edges of the fistula and a reduction in its size during the treatment period.
Before using this method, permission from our institution’s ethics com-
mittee was obtained. Silver nitrate was used after its modality had been ex-
plained and after obtaining each patient’s consent. The patients received
regular checkups after discharge from the hospital. After 1 month, the pa-
tients’ clinical data were monitored, and a chest radiograph and results
from flexible fiberoptic endoscopy were assessed.RESULTS
Seventeen patients (15 men and 2 women; mean age, 50
years; range, 14-75 years) with postoperative BPF were
treated using a conservative nonsurgicalmethod.Their under-
lying diseases were malignant (4 patients) and nonmalignant
(13 patients: 4 with bronchiectasis, 2 with pulmonary hydati-
dosis, 2 with pseudotumoral tuberculosis, 3 with a chronic
pulmonary abscess, 1 with aspergilloma, and 1 with infected
bullous emphysema).
Fifteen patients had undergone a lobectomy (13 right lo-
bectomies) and 2 had undergone a right pneumonectomy.
The margins around the surgical incisions in patients who
had a malignant disease were negative in frozen sections.
Clinical symptoms that led to a diagnosis of BPF were
a persistent air leak (n ¼ 2), a persistent air leak associated
with pleural empyema (n ¼ 3), pleural empyema alone
(n ¼ 11, identified from drainage fluids), and dyspnea
(n ¼ 1). Ten patients had abundant sputum. Chest x-ray576 The Journal of Thoracic and Cardiovascular Surgfilms showed hydropneumothorax (n ¼ 6), empyema
(n ¼ 8), atelectasis (n ¼ 1), and persistent pleural detach-
ment (n ¼ 2).
The mean interval between surgery and discovering the
fistula was 20 days (range, 5-270 days). The median diam-
eter of the BPF orifice was 3.3 mm (range, 2-9 mm). Fifteen
patients had a fistula of 5 mm or smaller. In all patients,
BPFs were localized on the bronchial stump, and 15 patients
had a fistula on the right side.
For the 16 patients who survived, the mean duration of
pleural drainage was 25 days (range, 4-70 days). Prophylac-
tic antibiotherapy was given to all patients and was adjusted
according to data from an antibiogram if one or more path-
ogens were isolated.
Fourteen patients had their chest tube removed during the
hospital stay. For 2 patients, empyema was not adequately
controlled by pleural drainage, despite complete fistula clo-
sure; thus, these patients were discharged with permanent
drainage.
The endoscopic procedure required 3 to 15 sessions, at an
average of 3 sessions per week. Themedian time until fistula
closurewas 14.5 days (range, 5-45 days).We did not observe
any complications during treatment with endoscopy.
The fistula of 1 patient (patient 16, Table 1) was 9 mm in
diameter. Hewas 55 years old, was obese, and had amedical
history of diabetes mellitus and a cardiac pathology. He had
undergone a right lower lobectomy for a chronic pulmonary
abscess. At 10 days after surgery, he developed a right hy-
dropneumothorax. Bronchoscopy showed inflammation of
the middle bronchus and a large fistula in the right lower
bronchus stump. Because of the patient’s general status
and, in particular, his medical history, we decided to treat
him bronchoscopically with a local application of silver ni-
trate to avoid life-threatening surgery. He received 15 ses-
sions, which resulted in successful complete closure of the
fistula and no complications from the endoscopic treatment
(Figure 1).
A BPF failed to close in a 75-year-old patient who had
undergone surgery (a right lower lobectomy) for a tissular
mass. The histological diagnosis was a metastatic pleomor-
phic carcinoma. He received 5 sessions of a silver nitrate ap-
plication, but he died of acute respiratory distress syndrome
related to aspiration pneumonia. Successful closure of the
fistula occurred in all the patients who survived (94.1%
treatment success).
Patients were re-examined bronchoscopically at 1 and
6 months after bronchoscopy, and no relapses occurred.
The overall average follow-up was 2 years, and patients
were then transferred to a pulmonologist for continued
management.
DISCUSSION
A BPF is the most serious postoperative complication
after lung resection, and can depend on the surgeon’sery c September 2013
TABLE 1. Patient characteristics and outcomes classified chronologically
Patient
no. Sex
Age,
y Surgical treatment
Size of
BPF,
mm
Time from
surgery, d
Complications,
symptoms
No. of
bronchoscopy
sessions
Time of
closure, d
Outcome of
treatment Follow-up
1 M 14 Left lower lobectomy 5 36 Fever, pyopneumothorax 6 20 Definitive closure No relapse
2 M 27 Right lower lobectomy 2 60 Fever, cough, pleural
empyema
5 27 Definitive closure No relapse
3 M 19 Right lower lobectomy 2 5 Fever, pyopneumothorax 5 14 Definitive closure No relapse
4 F 50 Left lower lobectomy 3 39 Chest pain, pleural
empyema
6 17 Definitive closure No relapse
5 M 58 Right lower lobectomy 2 34 Fever, chest pain, pleural
empyema
6 20 Definitive closure No relapse
6 M 65 Bilobectomy 5 15 Fever, pleural empyema 5 22 Definitive closure No relapse
7 M 50 Right lower lobectomy 5 13 Fever, persistent air leak,
pleural empyema
5 19 Definitive closure No relapse
8 F 31 Bilobectomy 1.5 30 Chest pain, pyopneumothorax 6 14 Definitive closure No relapse
9 M 62 Right pneumonectomy 1 15 Fever, pyopneumothorax 3 10 Definitive closure No relapse
10 M 46 Right pneumonectomy 1 270 Pleural empyema 5 13 Definitive closure No relapse
11 M 63 Right upper lobectomy 2 45 Pleural empyema 5 14 Definitive closure No relapse
12 M 49 Right upper lobectomy 2 30 Persistent pleural detachment 2 5 Definitive closure No relapse
13 M 47 Right upper lobectomy 3 20 Persistent air leak 9 25 Definitive closure No relapse
14 M 37 Left lower lobectomy 2 15 Fever, chest pain, pleural
empyema
8 18 Definitive closure No relapse
15 M 48 Right upper lobectomy 2 13 Fever, chest pain, persistent
air leak
4 8 Definitive closure No relapse
16 M 55 Right lower lobectomy 9 15 Hydropneumothorax 15 45 Definitive closure No relapse
17 M 75 Right lower lobectomy;
pleomorphic carcinoma
6 9 Empyema, fever, atelectasis 5 22 Failure? ARDS/death
BPF, Bronchopleural fistula; M, male; F, female; ARDS, acute respiratory distress syndrome.
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Sexperience, the use of neoadjuvant chemoradiation therapy,
a right-sided pneumonectomy, the length of the bronchial
stump, the type of bronchial closure, the predicted postop-
erative pulmonary function, and prolonged mechanical
ventilation.5
BPFs have been reported to occur in 4.5% to 20% of
cases after a pneumonectomy and in 0.5% of cases after
a lobectomy.1 Historically, the management of this compli-
cation has been a major challenge. It still occurs in 2% to
5% of all pulmonary resections.6 In our series, we had anFIGURE 1. Patient 16. Left, Dehiscence of the right lower bronchus stu
bronchopleural fistula closure after 15 sessions of local application of silver ni
The Journal of Thoracic and Caincidence of 0.93% after a pneumonectomy and 0.99% af-
ter a lobectomy. BPFs are associated with a serious mortal-
ity rate, ranging from 25% to 67%.7 The most common
cause of death is aspiration pneumonia with subsequent
acute respiratory distress syndrome, as occurred in the
one patient who died in our study. The relationship between
the increased incidence of BPFs and the use of staple su-
tures remains controversial.
The severity of the clinical features and the prognosis of
BPF are related to the surgical procedure: BPF is moremp producing a large 9-mm bronchopleural fistula. Right, Successful
trate.
rdiovascular Surgery c Volume 146, Number 3 577
TABLE 2. Management of BPF with different materials
Study Year Size Material Success rate,%
Varoli6 1998 35 Polidocanol 65
Hollaus9 1998 29 Fibrin glue 35
Tsunezuka10 1999 8 Fibrin glue 100
Tao11 2006 10 Collagen screw plug 90
Singh12 2005 1 Stenting 100
Hoier-Madson13 1984 10 Silver nitrate (rigid
bronchoscope)
No details
Stratakos7 2008 11 Silver nitrate (flexible
bronchoscope)
81.8
Our study 2010 17 Silver nitrate (flexible
bronchoscope)
94.1
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Sfrequent after a pneumonectomy. In fact, after a lobectomy,
the expansion of the residual parenchyma can minimize the
consequences of the fistula, whereas, after a pneumonectomy,
bronchial leakage frequently happens and is associated with
a high mortality rate, which can be up to 50%.6
The initial management of patients with BPF should in-
clude drainage of the infected pleural space, prophylactic
antibiotics, and adequate clearance of bronchial secretions.
The main challenge then remains to close the fistula. A va-
riety of surgical and bronchoscopic strategies for treating
BPFs have been described,5 although none of these ap-
proaches has been successful or suitable for all patients.8
The choice of treatment depends on the patient’s functional
status, how long until the BPF develops, and its size and
clinical features.
Aggressive surgical options, such as open-window drain-
age, thoracoplasty, omentopexy, intrathoracic muscle trans-
position, and a trans-sternal mediastinal approach, can be
problematic for an already compromised patient.7 There-
fore, many physicians attribute great importance to more
conservative treatments that involve drainage (and irriga-
tion of the pleural empyema, if it is present) and endoscopic
closure of the BPF.
We chose to not treat the fistula endoscopically when the
stump was still open, because the edges of the fistula were
still far apart: at that time point, the inflammation created
by the silver nitrate was considered insufficient to close
the orifice.
Several studies have been published on the application of
different materials through a bronchoscope to close BPFs
(Table 2). Varoli and colleagues6 investigated, in a series
of 35 patients, the value of applying polidocanol through
a flexible bronchoscope: this sclerotic agent is used fre-
quently to treat esophageal varices. The authors reported
that submucosal injections of polidocanol resulted in no se-
rious technical difficulties and no complications and had
a 65% success rate with permanent closure of fistulas mea-
suring up to 10 mm in diameter. Hollaus and colleagues9 re-
ported on 45 patients with a postoperative BPF, of whom 29
were treated endoscopically with fibrin glue or spongy calf578 The Journal of Thoracic and Cardiovascular Surgbone. The authors reported a 35% success rate and con-
cluded that the best results occurred in small, early fistulas.
In addition, Tsunezuka and colleagues10 developed a tube
system, made of 2-mm-diameter polypropylene, to endo-
scopically aerosolize fibrin glue (a biological adhesive) to
treat BPFs of less than 2 mm in diameter: they achieved
a 100% success rate.
Tao and colleagues11 designed an experimental animal
(dog) model for BPF occlusion using a collagen screw
plug. They hypothesized that the application of collagen,
which promotes cellular proliferation and wound healing,
would lead to a more favorable outcome: it successfully
treated 9 of 10 dogs that had a BPF of less than 8 mm in di-
ameter. Singh and colleagues12 reported successful closure
of a large post-pneumonectomy BPF using a tracheobron-
chial stent procedure in a 75-year-old woman. The aim of
stent placement was to curtail an air leak and allow effective
lung ventilation.
In this study, we present evidence for the management of
postoperative BPF using local application of silver nitrate
through a flexible bronchoscope.
The first use of silver nitrate was by Hoier-Madson and
colleagues13 in 1984. They successfully treated 10 patients
with BPF, after a pneumonectomy for non–small cell lung
cancer, through a rigid bronchoscope. The application of
silver nitrate caused tissue burns and local inflammation,
followed by the normal healing process and scar formation,
which achieved closure of the fistula. However, we have no
details of the exact techniques used or of the clinical find-
ings or follow-up data.
This technique was not repeated until 2008, when Strata-
kos and colleagues7 investigated the value of silver nitrate
applied to a BPF through a flexible videobronchoscope.
Eleven patients with 5-mm BPFs or smaller were enrolled
in their study. All underwent flexible videobronchoscopy
under conscious sedation. The authors used a standard bron-
choscopic cytology brush to apply the silver nitrate. Drops
of melted silver nitrate covered the entire surface of the cy-
tology brush and solidified. The bronchoscope was posi-
tioned as close as possible to the orifice of the fistula, and
the cytology brush was then passed through the working
channel of the bronchoscope and rubbed against the muco-
sal borders of the fistula in a circumferential movement for
5-s sessions until blanching and edema of the mucosa ap-
peared. The applicator was then retracted. This procedure
was repeated up to 10 times at intervals of 5 to 7 days until
the fistula had sealed effectively. The treatment procedure
required a mean of 2.5 (range, 1-10) bronchoscopic sessions
of silver nitrate application and resulted in complete closure
of the BPF in 9 patients (81.8% treatment success), but clo-
sure failure in 2 patients (18.18% treatment failure).
In our study, we enrolled 17 patients who had developed
post-pneumonectomy or post-lobectomy BPF with a fistula
size that ranged from 2 to 9 mm. In contrast to previousery c September 2013
Boudaya et al General Thoracic Surgeryreports, we did not exclude patients with a fistula size of 5
mm or greater. All patients were treated using a flexible vid-
eobronchoscope under local anesthesia.We used an intrave-
nous catheter to apply the silver nitrate. The results from the
local application of this caustic material were encouraging.
Effective and uneventful closure of the fistula was accom-
plished in 16 patients (94.1% treatment success), plus clin-
ical status was improved. There was only one failed BPF
closure, and this was in an aged patient with a poor clinical
status. Unlike the results of Stratakos and colleagues, we
needed the application of silver nitrate associated with
drainage and antibacterial therapy to obtain a good result.
Treatment of BPFs is not based solely on the manage-
ment of the fistula but also involves drainage and irrigation
of the pleura, and treating any infection with appropriate
antibiotics. This 3-pronged approach allows a global treat-
ment of the various components of this complication.G
T
SCONCLUSIONS
ABPF, although rare, is a therapeutic challenge and is as-
sociated with a high rate of morbidity and mortality. The
management of this postoperative complication includes
various surgical and medical procedures, including the re-
cent interest in endoscopic methods. Most of these interven-
tions have been described in series and case reports, but no
overall consensus has been established. Treatment needs to
be individualized. In high-risk surgical patients, endoscopic
procedures may serve as a temporary alternative until the
patient’s clinical status has improved; however, in other pa-
tients, endoscopic treatment may be the only option.
In our experience, we found that the application of silver
nitrate to mucosal tissue through a fiberoptic bronchoscopeThe Journal of Thoracic and Cawas easy, safe, nontraumatic, and effective: it allowed suc-
cessful closure of postoperative BPFs, even large fistulas
(up to 9 mm), and avoided the need for major surgical
intervention.
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